K Number
K170781
Device Name
MX50N(MX50YQS)
Manufacturer
Date Cleared
2017-04-04

(20 days)

Product Code
Regulation Number
892.2050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
MX50N(MX50YQS) LCD Monitor System is intended to be used in displaying and viewing digital medical images for review and analysis by trained medical practitioners. It is specifically designed for digital mammography applications and digital breast tomosynthesis applications.
Device Description
MX50N(MX50YQS) is a flat panel hi-resolution LCD monitor system for displaying digital medical images. The system consists of a state-of-the-art LCD monitor and a high-resolution graphic control board that connects to a PACS workstation for grayscale image display. The WIDE controller board is installed into the PACS workstation computer or other computer system to display PACS medical images.
More Information

No
The document describes a medical display monitor and its associated hardware for displaying medical images. There is no mention of AI, ML, or any related technologies for image analysis or processing. The performance studies focus on display characteristics like resolution and luminance.

No
The device is a monitor system used for displaying and viewing digital medical images, not for treating or diagnosing medical conditions. It serves as a tool for medical practitioners to review images, but it does not directly provide therapeutic intervention.

No

Explanation: The device is an LCD monitor system designed for displaying and viewing digital medical images. It does not perform analysis or diagnosis itself, but rather provides a visual representation of images for trained medical practitioners to review and analyze.

No

The device description explicitly states it consists of a "state-of-the-art LCD monitor and a high-resolution graphic control board," indicating it includes hardware components beyond just software.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is to display and view digital medical images for review and analysis by trained medical practitioners. This is a function related to image display and interpretation, not the analysis of biological samples or in vitro reactions.
  • Device Description: The device is described as a flat panel LCD monitor system and a graphic control board. This hardware is designed for displaying images, not for performing diagnostic tests on biological specimens.
  • Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), reagents, or any processes typically associated with in vitro diagnostics.

IVD devices are used to examine specimens taken from the human body to provide information for diagnosis, monitoring, or treatment. This device's function is to present existing medical images for visual review.

N/A

Intended Use / Indications for Use

MX50N(MX50YQS) LCD Monitor System is intended to be used in displaying and viewing digital medical images for review and analysis by trained medical practitioners. It is specifically designed for digital mammography applications and digital breast tomosynthesis applications.

Product codes (comma separated list FDA assigned to the subject device)

PGY

Device Description

MX50N(MX50YQS) is a flat panel hi-resolution LCD monitor system for displaying digital medical images. The system consists of a state-of-the-art LCD monitor and a high-resolution graphic control board that connects to a PACS workstation for grayscale image display. The WIDE controller board is installed into the PACS workstation computer or other computer system to display PACS medical images.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

digital mammography, digital breast tomosynthesis

Anatomical Site

breast

Indicated Patient Age Range

Not Found

Intended User / Care Setting

trained medical practitioners

Description of the training set, sample size, data source, and annotation protocol

No clinical studies were considered necessary and performed.

Description of the test set, sample size, data source, and annotation protocol

No clinical studies were considered necessary and performed.

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The device was validated through non-clinical testing. The tests conducted for resolution, luminance, contrast and noise all met the acceptance criteria specified in the standards IEC 60601-1 and IEC 60601-1-2.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K160326

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

K160353

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

0

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

April 4, 2017

WIDE Corporation % YeoJin Yun RA Manager 12 Wongomae-Ro, Giheung-Gu Yongin-Si, Gyeonggi-Do 17086 REPUBLIC OF KOREA

Re: K170781

Trade/Device Name: MX50N(MX50YOS) Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: PGY Dated: March 10, 2017 Received: March 17, 2017

Dear YeoJin Yun:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

1

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

Michael D'Hara

For

Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K170781

Device Name MX50N(MX50YQS)

Indications for Use (Describe)

MX50N(MX50YQS) LCD Monitor System is intended to be used in displaying and viewing digital medical images for review and analysis by trained medical practitioners. It is specifically designed for digital mammography applications and digital breast tomosynthesis applications.

Type of Use (Select one or both, as applicable)

2 Prescription Use (Part 21 CFR 801 Subpart D)

_ Over-The-Counter Use (21 CFR 801 Subpart C)

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.

FOR FDA USE ONLY

Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

510(k) Summary

[As required by 21 CFR 807.92]

This 510(k) summary of safety and effectiveness information is prepared in accordance with 21 CFR 807.92

1. Date Prepared [21 CFR 807.92(a) (1)]

03/10//2017

2. Submitter's Information [21 CFR 807.92(a) (1)]

Name of Sponsor:WIDE Corporation.
Address:12 Wongomae-Ro, Giheung-Gu, Yongin-Si, Gyeonggi-Do
17086, Republic of Korea
Contact Name:YeoJin Yun
Telephone #: +82-31-218-1675
Fax #: +82-31-218-7400
Email: yyjin@widecorp.com
Registration Number:3004082357
Name of Manufacturer:Same as Sponsor

3. Trade Name, Common Name, Classification [21 CFR 807.92(a) (2)]

Model Name:MX50N(MX50YQS)
Common Name:TFT LCD Medical Monitor System
Classification Name:Display, Diagnostic Radiology
Regulation Number:21 CFR 892.2050
Product Code:PGY
Device Class:2
Review Panel:Radiology

4. Identification of Predicate Device(s) [21 CFR 807.92(a) (3)]

510(k) Number: K160326
Applicant: JVC KENWOOD Corporation
Model Name: 5MP Monochrome LCD Monitor MS55i2
(ML21055, MD211G5)
Common Name: TFT LCD Medical Monitor System
Classification Name: Display, Diagnostic Radiology
Regulation Number: 21 CFR 892.2050
Product Code: PGY
Device Class: 2

4

5. Description of the Device [21 CFR 807.92(a) (4)]

MX50N(MX50YQS) is a flat panel hi-resolution LCD monitor system for displaying digital medical images. The system consists of a state-of-the-art LCD monitor and a high-resolution graphic control board that connects to a PACS workstation for grayscale image display. The WIDE controller board is installed into the PACS workstation computer or other computer system to display PACS medical images.

Subject of this new 510(k) premarket notification is an addition to the indications for use for the MX50N(MX50YQS). The device was cleared via premarket notification K160353. There is no any change of configuration/components and functionality of the subject device as compared with cleared device (K160353).

6. Intended Use [21 CFR 807.92(a) (5)]

The MX50N(MX50YQS) LCD Monitor System is intended to be used in displaying and viewing digital medical images for review and analysis by trained medical practitioners. It is specifically designed for digital mammography applications and digital breast tomosynthesis applications.

7. Technological Characteristics [21 CFR 807.92(a) (6)]

The device is an image display system which consists of computer software and components. The device does not contact the patient, nor does it control any life sustaining devices. A physician or trained medical practitioner provides ample opportunity for competent human intervention to interpret images and information being displayed.

ParameterSubject DevicePredicate Device
510(k) NumberUnknownK160326
Model NameMX50N(MX50YQS)5MP Monochrome LCD
Monitor MS55i2
(ML21055, MD211G5)
ManufacturerWIDE Corporation.JVC KENWOOD Corporation
Common NameTFT LCD Medical Monitor System
Classification NameDisplay, Diagnostic Radiology
Classification PanelRadiology
Classification Regulation21 CFR 892.2050
Product CodePGY
Device ClassClass II
Intended UseThe MX50N(MX50YQS) LCD
Monitor System is intended to be
used in displaying and viewing5MP Monochrome LCD
Monitor MS55i2 (ML21055,
MD211G5) are intended to be

8. Substantial Equivalence [21 CFR 807.92(b) (1) and 807.92]

5

ParameterSubject DevicePredicate Device
digital medical images for review
and analysis by trained medical
practitioners. It is specifically
designed for digital mammography
applications and digital breast
tomosynthesis applications.used in displaying and viewing
medical images for diagnosis by
trained medical practitioners.
They are to be used in digital
mammography PACS
modalities including FFDM, and
breast tomosynthensis.
Response Time
(Typical)25ms (On/Off)25ms (On/Off)
LCD Panel Size21.3"21.3"
Resolution2560 x 20482560 x 2048
Pixel pitch0.165mm x 0.165mm0.165mm x 0.165mm
Brightness1200cd/m²1200cd/m²
Contrast Ratio1000 : 11200 : 1
Input SignalDVI-I, DisplayPortDVI-I
Power Supply100~240 VAC, 50/60Hz100~240 VAC, 50/60Hz
Color/MonochromeMonochromeMonochrome

When compared to the predicate devices (K160326), the MX50N(MX50YQS) presented in this submission has the same of the followings:

  • Intended Use
  • Technological characteristics
  • Response Time
  • LCD Panel Size
  • Resolution
  • Pixel pitch
  • · Brightness

The two devices share the similar performance as the following:

  • Contrast Ratio
    There is no significant difference between the MX50N(MX50YQS) and the predicate device that would adversely affect the use of the product. The subject device is substantially equivalent to the predicate device in intended use, technological characteristics, panel size, resolution, pixel pitch, Brightness and contrast ratio.

6

9. Summary of Non-Clinical Data

MX50N(MX50YQS) comply with the following international and FDA-recognized consensus standards:

| IEC 60601-1: | Medical Electrical Equipment -- Part 1: General
Requirements For Basic Safety And Essential Performance |
|----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IEC 60601-1-2: | Medical Electrical Equipment - Part 1-2: General
Requirements For Basic Safety And Essential Performance -
Collateral Standard: Electromagnetic Compatibility -
Requirements And Tests |

The tests conducted for resolution, luminance, contrast and noise all met the acceptance criteria specified in the standards.

10. Summary of Clinical Data

No clinical studies were considered necessary and performed.

11. Conclusion [21 CFR 807.92(b) (3)]

Subject Device is substantially equivalent to the currently marketed and predicate devices in terms of design features, fundamental scientific technology, indications for use, and safety and effectiveness. Even though the predicate device and the subject device differ in the brightness, the difference is not a critical in the effectiveness because subject device covers brightness range of predicate device.

Additionally, the safety of the subject device was validated through tests including IEC60601-1 and IEC 60601-1-2. The effectiveness of the device was validated through tests for resolution, luminance, contrast and noise.

The results of these tests demonstrate that MX50N(MX50YQS) meets the acceptance criteria and is adequate for this intended use. The comparison of technological characteristics, nonclinical performance data, safety testing demonstrates that the device is as safe and effective as the predicate device and performs as well as the predicate device.